To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TUBB6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
395 supporting clones for gene TUBB6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CX866060 embryonic stem .a 1 to 735 1 to 735   tiling clone,   735/735
(100 %)
5 diff
(99.4 %id)
AL517109 brain, neuroblastoma, neuroblastoma cells .a 155 to 977 1 to 818       818/818
(100 %)
9 diff
(98.9 %id)
CR616368 fetal brain .a 163 to 2002 1 to 1840 exact     1840/1840
(100 %)
0 diff
(100 %id)
AL540245 brain, fetal brain .a 163 to 1055 1 to 883   fully sequenced,   883/883
(100 %)
8 diff
(99.1 %id)
BQ233367 epithelioid carcinoma, Pancreas .a 163 to 969 1 to 815       815/921
(88 %)
14 diff
(98.5 %id)
BQ687284 ductal carcinoma, cell line, Pancreas .a 169 to 1049 1 to 893       893/894
(99 %)
20 diff
(97.8 %id)
BQ691134 ductal carcinoma, cell line, Pancreas .a 169 to 1056 1 to 915       873/919
(94 %)
48 diff
(94.8 %id)
CR595733 Placenta Cot 25-normalized .a 179 to 1985 1 to 1807 exact     1807/1807
(100 %)
0 diff
(100 %id)
CR605380 Placenta Cot 25-normalized .a 179 to 1990 1 to 1812 exact     1812/1812
(100 %)
0 diff
(100 %id)
TI_57165154   .a 179 to 1006 52 to 903       852/903
(94 %)
49 diff
(94.6 %id)
DA595988   .a 187 to 952 2 to 776   capped   775/775
(100 %)
12 diff
(98.5 %id)
AK001295   .a 188 to 2018 1 to 1831 exact tiling clone, available from FLJ,   1831/1831
(100 %)
0 diff
(100 %id)
AK022340 mammary gland .a 188 to 2011 1 to 1824 I91V available from FLJ,   1824/1824
(100 %)
3 diff
(99.9 %id)
AK098440 thyroid .a 188 to 2011 1 to 1824 exact available from FLJ,   1824/1829
(99 %)
3 diff
(99.9 %id)
DB444915 testis .a 188 to 611 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
BJ992225 hepatoblastoma .a 188 to 724 1 to 537       537/537
(100 %)
2 diff
(99.7 %id)
DA131637 alzheimer cortex .a 189 to 732 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA384325 thalamus .a 189 to 760 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA687962   .a 189 to 717 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA691275   .a 189 to 754 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA712911   .a 189 to 739 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA730423   .a 189 to 927 2 to 742   capped   741/745
(99 %)
5 diff
(99.4 %id)
AU127951   .a 189 to 891 2 to 703   capped   702/702
(100 %)
17 diff
(97.6 %id)
AU128052   .a 189 to 772 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
DA037226   .a 190 to 949 2 to 758   capped   757/816
(92 %)
5 diff
(99.4 %id)
BM044943 carcinoma, cell line, Prostate .a 193 to 1099 1 to 894       894/903
(99 %)
30 diff
(96.7 %id)
TI_45211367   .a 195 to 898 127 to 836       710/839
(84 %)
12 diff
(98.6 %id)
DA609099   .a 196 to 759 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
TI_57162298   .a 197 to 1103 1 to 902       902/914
(98 %)
23 diff
(97.5 %id)
BM699649 eye, lens .a 198 to 690 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
BM916277 amelanotic melanoma, cell line, skin .a 199 to 1005 1 to 818       818/1138
(71 %)
17 diff
(98.6 %id)
BU541576 carcinoma, cell line, Prostate .a 199 to 1080 1 to 886       886/905
(97 %)
8 diff
(99.2 %id)
TI_57162374   .a 199 to 978 29 to 820       792/820
(96 %)
27 diff
(96.8 %id)
NM_032525.1   .a 200 to 2018 6 to 1824 exact RefSeq, AAA   1819/1824
(99 %)
6 diff
(99.7 %id)
BY997443   .a 201 to 819 1 to 619       619/619
(100 %)
5 diff
(99.2 %id)
BM476328 duodenal adenocarcinoma, cell line, small intestine .a 202 to 1220 1 to 1031       1031/1056
(97 %)
26 diff
(97.6 %id)
BU956061 adenocarcinoma, cell line, breast .a 202 to 981 1 to 786       786/955
(82 %)
16 diff
(98.4 %id)
BG762997 melanotic melanoma, high MDR (cell line), skin .a 203 to 1192 1 to 980       980/994
(98 %)
42 diff
(95.8 %id)
BG766609 melanotic melanoma, high MDR (cell line), skin .a 203 to 1015 1 to 817       817/818
(99 %)
15 diff
(98.2 %id)
AL545031 placenta, Placenta Cot 25-normalized .a 204 to 1100 22 to 907   fully sequenced,   886/907
(97 %)
9 diff
(99.1 %id)
BG116477 duodenal adenocarcinoma, cell line, small intestine .a 204 to 952 1 to 747       747/1095
(68 %)
26 diff
(97.7 %id)
BG282208 melanotic melanoma, skin .a 204 to 1133 1 to 918       918/922
(99 %)
34 diff
(96.4 %id)
BG397146 melanotic melanoma, skin .a 204 to 1063 1 to 860       860/862
(99 %)
13 diff
(98.5 %id)
BG683374 brain, neuroblastoma, cell line .a 204 to 1048 1 to 841       841/842
(99 %)
15 diff
(98.3 %id)
BM552127 leiomyosarcoma, uterus .a 204 to 1143 1 to 947       947/978
(96 %)
23 diff
(97.7 %id)
BQ224987 leiomyosarcoma, uterus .a 204 to 1206 1 to 1004       1004/1004
(100 %)
22 diff
(97.9 %id)
TI_59381187   .a 204 to 1015 99 to 943       845/874
(96 %)
57 diff
(93.5 %id)
BC002654 Uterus, endometrium adenocarcinoma .a 205 to 2018 11 to 1824 exact available from MGC, AAA   1814/1814
(100 %)
0 diff
(100 %id)
CR607214 fetal liver .a 205 to 2005 1 to 1801 exact     1801/1801
(100 %)
0 diff
(100 %id)
BM800175 leiomyosarcoma, uterus .a 205 to 1140 1 to 939       939/1006
(93 %)
16 diff
(98.5 %id)
CX758005 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 205 to 943 1 to 738     Submitted on the opposite strand 738/738
(100 %)
5 diff
(99.4 %id)
TI_57150219   .a 205 to 1008 28 to 842       815/842
(96 %)
31 diff
(96.4 %id)
DA376254 thalamus .a 206 to 763 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BX459088 placenta .a 206 to 1234 1 to 1009       1009/1012
(99 %)
29 diff
(97.2 %id)
BM810869 amelanotic melanoma, cell line, skin .a 206 to 1018 1 to 823       823/1093
(75 %)
15 diff
(98.7 %id)
BM915105 amelanotic melanoma, cell line, skin .a 206 to 1184 1 to 989       989/1003
(98 %)
20 diff
(98.1 %id)
BM915911 amelanotic melanoma, cell line, skin .a 206 to 1197 1 to 992       992/992
(100 %)
13 diff
(98.7 %id)
AL533726 brain, fetal brain .a 208 to 1108 1 to 894   fully sequenced,   894/894
(100 %)
15 diff
(98.4 %id)
DA573484   .a 208 to 745 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BG252228 adenocarcinoma, cell line, Liver .a 208 to 1052 1 to 851       851/894
(95 %)
34 diff
(96.2 %id)
DA850329 placenta .a 208 to 764 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BM016666 astrocytoma grade IV, cell line, brain .a 209 to 1115 1 to 897       897/973
(92 %)
26 diff
(97.4 %id)
CR593665 Placenta Cot 25-normalized .a 210 to 2005 1 to 1796 exact     1796/1796
(100 %)
0 diff
(100 %id)
CR593961 Placenta Cot 25-normalized .a 210 to 2006 1 to 1797 exact     1797/1797
(100 %)
0 diff
(100 %id)
AL543562 placenta, Placenta Cot 25-normalized .a 210 to 966 1 to 750   fully sequenced,   750/750
(100 %)
4 diff
(99.5 %id)
AL551673 placenta, Placenta Cot 25-normalized .a 210 to 1126 1 to 906   fully sequenced,   906/906
(100 %)
8 diff
(99.2 %id)
TI_59386899   .a 210 to 1115 105 to 1000       896/972
(92 %)
25 diff
(97.5 %id)
CX759789 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 211 to 978 1 to 761     Submitted on the opposite strand 761/765
(99 %)
10 diff
(98.7 %id)
DR156202 human embryonic stem cells differentiated toan early endodermal cell type .a 211 to 989 1 to 779       779/779
(100 %)
1 diff
(99.9 %id)
CD514731 White Matter .a 211 to 1042 1 to 834       834/850
(98 %)
3 diff
(99.7 %id)
TI_59395867   .a 212 to 1044 62 to 900       839/840
(99 %)
22 diff
(97.4 %id)
BG477574 melanotic melanoma, skin .a 213 to 1099 1 to 889       889/931
(95 %)
44 diff
(95.3 %id)
DA023135   .a 214 to 784 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA037385   .a 214 to 1062 2 to 853   capped   852/857
(99 %)
19 diff
(97.8 %id)
BM556773 amelanotic melanoma, cell line, skin .a 214 to 1013 1 to 807       807/1039
(77 %)
31 diff
(97.1 %id)
BQ686282 ductal carcinoma, cell line, Pancreas .a 214 to 1038 1 to 831       831/836
(99 %)
14 diff
(98.4 %id)
BM911966 amelanotic melanoma, cell line, skin .a 215 to 1042 1 to 834       834/1100
(75 %)
19 diff
(98.3 %id)
BU153430 epithelioid carcinoma, Pancreas .a 216 to 1124 1 to 910       910/912
(99 %)
26 diff
(97.2 %id)
BM562569 amelanotic melanoma, cell line, skin .a 219 to 1086 1 to 881       881/1050
(83 %)
16 diff
(98.5 %id)
AU136219 placenta .a 220 to 981 2 to 764   capped   763/763
(100 %)
12 diff
(98.5 %id)
BM761047 lymph node, stomach .a 222 to 896 1 to 675       675/675
(100 %)
0 diff
(100 %id)
BQ430542 epithelioid carcinoma, Pancreas .a 223 to 1056 1 to 851       851/931
(91 %)
20 diff
(97.9 %id)
BQ437920 leiomyosarcoma, uterus .a 223 to 1048 1 to 841       841/892
(94 %)
29 diff
(96.8 %id)
BE276859 melanotic melanoma, skin .a 224 to 758 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BE562844 endometrium, adenocarcinoma cell line, uterus .a 225 to 1045 1 to 810       810/1131
(71 %)
25 diff
(97.8 %id)
CN367562 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 226 to 902 1 to 677       677/677
(100 %)
0 diff
(100 %id)
DA997449   .a 226 to 696 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
BM810446 astrocytoma grade IV, cell line, brain .a 229 to 1127 1 to 911       911/1035
(88 %)
31 diff
(97.1 %id)
DR157021 human embryonic stem cells differentiated toan early endodermal cell type .a 229 to 1063 1 to 835       835/835
(100 %)
1 diff
(99.9 %id)
BM806116 leiomyosarcoma, uterus .a 230 to 1218 1 to 994       994/1056
(94 %)
36 diff
(96.6 %id)
BE409066 choriocarcinoma, placenta .a 231 to 887 1 to 656       656/671
(97 %)
4 diff
(99.5 %id)
BX458869 placenta .a 232 to 1299 1 to 1061       1061/1061
(100 %)
17 diff
(98.4 %id)
BE409437 choriocarcinoma, placenta .a 232 to 835 1 to 604       604/604
(100 %)
0 diff
(100 %id)
CR594370 Placenta Cot 25-normalized .a 233 to 2001 1 to 1769 exact     1769/1769
(100 %)
0 diff
(100 %id)
AL552305 placenta, Placenta Cot 25-normalized .a 233 to 1103 1 to 868   fully sequenced,   868/868
(100 %)
5 diff
(99.5 %id)
BE384071 melanotic melanoma, skin .a 233 to 796 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BG680821 skin, squamous cell carcinoma .a 238 to 1062 1 to 829       829/829
(100 %)
6 diff
(99.3 %id)
BQ683639 melanotic melanoma, cell line, skin .a 240 to 1145 24 to 936       913/950
(96 %)
26 diff
(97.3 %id)
TI_44159191   .a 240 to 841 53 to 656       604/657
(91 %)
9 diff
(98.7 %id)
CN367582 embryonic stem cells, cell lines H1, H7, andH9 .a 243 to 917 1 to 675       675/675
(100 %)
0 diff
(100 %id)
BQ948802 leiomyosarcoma, uterus .a 246 to 1069 1 to 836       836/981
(85 %)
26 diff
(97.4 %id)
DN602236 human embryonic stem cells .a 251 to 1101 1 to 851       851/851
(100 %)
1 diff
(99.9 %id)
BQ217124 large cell carcinoma, lung .a 252 to 1042 1 to 794       794/865
(91 %)
5 diff
(99.5 %id)
CV815892 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 252 to 1100 1 to 855       855/890
(96 %)
28 diff
(96.9 %id)
BG423360 Kidney, renal cell adenocarcinoma .a 254 to 1102 1 to 844       844/844
(100 %)
48 diff
(94.4 %id)
CD519321 White Matter .a 254 to 1095 1 to 848       848/909
(93 %)
21 diff
(97.7 %id)
BM473459 duodenal adenocarcinoma, cell line, small intestine .a 256 to 1074 33 to 860       828/1238
(66 %)
31 diff
(97.5 %id)
CN367569 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 271 to 870 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BE910086 epithelioid carcinoma, Pancreas .a 272 to 930 1 to 659       659/662
(99 %)
2 diff
(99.7 %id)
BM044928 carcinoma, cell line, Prostate .a 281 to 1141 1 to 848       848/904
(93 %)
23 diff
(97.5 %id)
CN367564 embryonic stem cells, DMSO-treated H9 cellline .a 288 to 937 1 to 650       650/650
(100 %)
0 diff
(100 %id)
TI_57228441   .a 308 to 1134 53 to 876       824/824
(100 %)
6 diff
(99.3 %id)
BI870708 adenocarcinoma, cell line, Liver .a 309 to 1134 1 to 823       823/823
(100 %)
6 diff
(99.3 %id)
BQ945974 leiomyosarcoma, uterus .a 313 to 1225 24 to 946       923/962
(95 %)
32 diff
(96.7 %id)
TI_59385082   .a 376 to 1111 65 to 796       732/732
(100 %)
14 diff
(98.1 %id)
BM550899 amelanotic melanoma, cell line, skin .a 377 to 1430 1 to 1050       1050/1058
(99 %)
17 diff
(98.4 %id)
BM558512 amelanotic melanoma, cell line, skin .a 377 to 1365 1 to 996       996/1036
(96 %)
40 diff
(96.2 %id)
BM916793 amelanotic melanoma, cell line, skin .a 378 to 1303 1 to 938       938/1127
(83 %)
48 diff
(95.8 %id)
BQ943403 brain, neuroblastoma, cell line .a 394 to 1324 5 to 943       939/946
(99 %)
24 diff
(97.5 %id)
CX866213.
matches multiple genes
embryonic stem .a 436 to 1246 1 to 811     also hits gene chermerbo 811/811
(100 %)
0 diff
(100 %id)
BM800652 leiomyosarcoma, uterus .a 439 to 1283 1 to 849       849/1039
(81 %)
26 diff
(97.5 %id)
BM464478 leiomyosarcoma, uterus .a 452 to 1400 1 to 955       955/1092
(87 %)
17 diff
(98.5 %id)
BG832338 epithelioid carcinoma cell line, Pancreas .a 469 to 1361 1 to 907       907/996
(91 %)
49 diff
(95.1 %id)
AL570105 placenta, Placenta Cot 25-normalized .a 936 to 2006 1061 to 1   fully sequenced,   1061/1061
(100 %)
13 diff
(98.8 %id)
AL568294 brain, fetal brain .a 1025 to 2002 973 to 1   fully sequenced,   973/973
(100 %)
23 diff
(97.7 %id)
AL544998 placenta, Placenta Cot 25-normalized .a 1070 to 1985 910 to 1   fully sequenced,   910/910
(100 %)
5 diff
(99.5 %id)
AL575637 placenta, Placenta Cot 25-normalized .a 1073 to 2000 928 to 1   fully sequenced,   928/928
(100 %)
4 diff
(99.6 %id)
AL533725 brain, fetal brain .a 1078 to 2001 927 to 1   fully sequenced,   927/927
(100 %)
5 diff
(99.5 %id)
AL575265 placenta, Placenta Cot 25-normalized .a 1096 to 1969 902 to 38   fully sequenced, AAA   865/876
(98 %)
7 diff
(99.3 %id)
AL517108 brain, neuroblastoma, neuroblastoma cells .a 1132 to 1936 856 to 50   AAA   807/820
(98 %)
0 diff
(100 %id)
TI_44159192   .a 1177 to 1970 799 to 2       798/799
(99 %)
0 diff
(100 %id)
BG683973 brain, neuroblastoma, cell line .a 1218 to 1968 757 to 7       751/760
(98 %)
0 diff
(100 %id)
BU737471 eye, lens .a 1353 to 2013 679 to 19   AAA   661/661
(100 %)
0 diff
(100 %id)
CX865991 embryonic stem .a 1412 to 2017 631 to 26   AAA   606/606
(100 %)
1 diff
(99.9 %id)
AU150323   .a 1423 to 2018 594 to 1       594/596
(99 %)
10 diff
(98.4 %id)
AU150381   .a 1436 to 2018 584 to 1       584/584
(100 %)
11 diff
(98.2 %id)
DB353288   .a 1478 to 2026 548 to 1   tiling clone,   548/553
(99 %)
10 diff
(98.2 %id)
BJ992226 hepatoblastoma .a 1525 to 1984 460 to 1       460/460
(100 %)
0 diff
(100 %id)
DB319785   .a 1560 to 2018 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AU156578 placenta .a 1616 to 2018 403 to 1       403/403
(100 %)
5 diff
(98.8 %id)
CR614714 placenta .b 1 to 1726 1 to 1726 exact tiling clone,   1726/1726
(100 %)
0 diff
(100 %id)
BP329551 rectum .b 12 to 634 1 to 624       624/624
(100 %)
6 diff
(99.1 %id)
BP268791 thyroid .b 17 to 596 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP269131 thyroid .b 17 to 599 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BX417481 placenta .b 26 to 973 22 to 962   fully sequenced,   941/962
(97 %)
12 diff
(98.8 %id)
BM476704 leiomyosarcoma, uterus .b 33 to 1007 1 to 986       986/1081
(91 %)
38 diff
(96.5 %id)
BM454846 leiomyosarcoma, uterus .b 35 to 950 1 to 928       928/971
(95 %)
20 diff
(98.0 %id)
BQ650172 hepatocellular carcinoma, cell line, Liver .b 36 to 856 1 to 827       827/894
(92 %)
20 diff
(97.8 %id)
BQ649928 hepatocellular carcinoma, cell line, Liver .b 36 to 962 1 to 928       928/933
(99 %)
22 diff
(97.7 %id)
BQ652795 hepatocellular carcinoma, cell line, Liver .b 36 to 780 1 to 748       748/944
(79 %)
30 diff
(96.9 %id)
BE908682 epithelioid carcinoma, Pancreas .b 56 to 731 1 to 670       670/1129
(59 %)
13 diff
(98.9 %id)
BX454456 placenta .b 943 to 1725 778 to 1   fully sequenced,   778/778
(100 %)
12 diff
(98.5 %id)
AK092677   .c 1 to 2163 1 to 2163   tiling clone, available from FLJ,   2163/2163
(100 %)
1 diff
(100.0 %id)
DA024542   .c 2 to 462 2 to 461   capped   460/460
(100 %)
5 diff
(99.0 %id)
DA576618   .c 2 to 517 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
DA881173   .c 2 to 238 2 to 239   capped   238/238
(100 %)
1 diff
(99.6 %id)
BQ954069 brain, neuroblastoma, cell line .c 12 to 554 1 to 545       545/1000
(54 %)
18 diff
(98.2 %id)
BQ069588 brain, neuroblastoma, cell line .c 24 to 666 1 to 643       643/1101
(58 %)
8 diff
(99.3 %id)
CN367573 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 268 to 869 1 to 602       602/602
(100 %)
3 diff
(99.6 %id)
DA986302 synovial membrane tissue from rheumatioidarthritis .c 318 to 877 17 to 576   capped   560/560
(100 %)
3 diff
(99.5 %id)
BE886960 leiomyosarcoma, uterus .c 329 to 667 1 to 340       340/508
(66 %)
3 diff
(99.5 %id)
BP377745 uterus .c 350 to 916 1 to 568       568/568
(100 %)
4 diff
(99.3 %id)
DA700372   .c 352 to 846 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DA535771 heart .c 353 to 929 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BM563348 astrocytoma grade IV, cell line, brain .c 434 to 1258 1 to 832       832/1053
(79 %)
17 diff
(98.4 %id)
TI_227714158   .c 1264 to 2215 1041 to 95   AAA   947/948
(99 %)
16 diff
(98.4 %id)
CD367325 Alveolar Macrophage, lung .c 1487 to 2176 708 to 19   AAA   690/690
(100 %)
0 diff
(100 %id)
CD364877 Alveolar Macrophage, lung .c 1490 to 2215 744 to 19   tiling clone, AAA   726/726
(100 %)
4 diff
(99.5 %id)
DB330350   .c 1615 to 2163 550 to 1       550/550
(100 %)
1 diff
(99.9 %id)
AI687892 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 2073 to 2177 105 to 1       105/105
(100 %)
0 diff
(100 %id)
BP385333 pancreatic islet .d-u 1 to 412 413 to 1   tiling clone,   413/413
(100 %)
1 diff
(99.8 %id)
BQ694983 adipose .d-u 13 to 599 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BQ695151 adipose .d-u 13 to 628 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
BU149943 dorsal root ganglia .d-u 15 to 928 1 to 920   tiling clone,   920/965
(95 %)
17 diff
(98.3 %id)
BQ938805 sciatic nerve .d-u 15 to 741 1 to 733       733/983
(74 %)
17 diff
(98.3 %id)
CN367567 embryonic stem cells, cell lines H1, H7, andH9 .d-u 23 to 694 1 to 672       672/672
(100 %)
2 diff
(99.8 %id)
CB149474 Liver .d-u 46 to 553 8 to 515       508/515
(98 %)
8 diff
(98.5 %id)
BQ951932 epidermoid carcinoma, cell line, lung .d-u 305 to 1125 9 to 839       831/975
(85 %)
37 diff
(96.3 %id)
CN367578 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d-u 309 to 898 1 to 590       590/590
(100 %)
0 diff
(100 %id)
DR763340 embryonic stem .d-u 327 to 1171 1 to 844       844/844
(100 %)
1 diff
(99.9 %id)
CV812805 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d-u 328 to 1168 1 to 845       845/890
(94 %)
34 diff
(96.2 %id)
CV804011 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d-u 328 to 1167 1 to 843       843/886
(95 %)
29 diff
(96.8 %id)
CX753927 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d-u 328 to 952 1 to 625     Submitted on the opposite strand 625/625
(100 %)
0 diff
(100 %id)
BG749046 eye, normal pigmented retinal epithelium .d-u 336 to 1219 1 to 877       877/878
(99 %)
17 diff
(98.1 %id)
BF770019 epid_tumor .d-u 393 to 758 366 to 1     Submitted on the opposite strand 366/366
(100 %)
5 diff
(98.7 %id)
BQ347514 head_neck .d-u 423 to 691 292 to 14       279/292
(95 %)
0 diff
(100 %id)
BM459896 leiomyosarcoma, uterus .d-u 435 to 1283 1 to 854       854/1080
(79 %)
19 diff
(98.3 %id)
CN367568 embryonic stem cells, cell lines H1, H7, andH9 .d-u 488 to 1054 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BM543137 duodenal adenocarcinoma, cell line, small intestine .d-u 502 to 1504 1 to 1013       1013/1045
(96 %)
46 diff
(95.6 %id)
CB105745 Liver .d-u 509 to 996 1 to 488       488/488
(100 %)
0 diff
(100 %id)
CB105747 Liver .d-u 509 to 982 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BG698171 skin .d-u 604 to 1311 1 to 706       706/706
(100 %)
4 diff
(99.5 %id)
CB149027 Liver .d-u 632 to 1077 1 to 446       446/446
(100 %)
0 diff
(100 %id)
TI_1948154208   .d-u 656 to 1367 847 to 124       724/1456
(49 %)
0 diff
(100 %id)
BE885445 leiomyosarcoma, uterus .d-u 679 to 1380 1 to 701       701/705
(99 %)
2 diff
(99.8 %id)
TI_59395131   .d-u 683 to 1383 65 to 776   fully sequenced,   712/712
(100 %)
3 diff
(99.6 %id)
BM556599 duodenal adenocarcinoma, cell line, small intestine .d-u 692 to 1588 1 to 909       909/1033
(87 %)
33 diff
(96.9 %id)
AW629643 2 pooled high-grade transitional celltumors, genitourinary tract .d-u 698 to 1293 1 to 594   fully sequenced,   594/594
(100 %)
4 diff
(99.4 %id)
BX100686 breast .d-u 727 to 1471 1 to 745   tiling clone,   745/745
(100 %)
0 diff
(100 %id)
BF916524 uterus_tumor .d-u 754 to 1066 1 to 313       313/313
(100 %)
0 diff
(100 %id)
BG768834 melanotic melanoma, high MDR (cell line), skin .d-u 762 to 1376 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BM809216 amelanotic melanoma, cell line, skin .d-u 838 to 1793 25 to 985   AAA   961/985
(97 %)
19 diff
(98.1 %id)
TI_227712869   .d-u 849 to 1806 1023 to 78   AAA   946/1033
(91 %)
6 diff
(99.5 %id)
TI_149288231   .d-u 854 to 1806 1003 to 66   AAA   938/1005
(93 %)
29 diff
(97.2 %id)
BM553849 duodenal adenocarcinoma, cell line, small intestine .d-u 861 to 1667 1 to 818       818/1014
(80 %)
33 diff
(96.8 %id)
TI_227712966   .d-u 926 to 1814 959 to 82   tiling clone, AAA   878/1014
(86 %)
10 diff
(99.1 %id)
TI_149314295   .d-u 932 to 1789 929 to 90   AAA   840/963
(87 %)
25 diff
(97.5 %id)
BX434271 placenta .d-u 933 to 1799 872 to 4     Submitted on the opposite strand 869/873
(99 %)
0 diff
(100 %id)
TI_149298888   .d-u 943 to 1806 942 to 92   AAA   851/947
(89 %)
21 diff
(97.8 %id)
BU957759 adenocarcinoma, cell line, breast .d-u 954 to 1731 1 to 786       786/953
(82 %)
16 diff
(98.4 %id)
BM553246 amelanotic melanoma, cell line, skin .d-u 964 to 1806 1 to 843   AAA   843/843
(100 %)
3 diff
(99.7 %id)
TI_227715328   .d-u 967 to 1799 914 to 97   AAA   818/957
(85 %)
19 diff
(98.1 %id)
TI_154038625   .d-u 978 to 1806 887 to 61   AAA   827/973
(84 %)
5 diff
(99.5 %id)
CB158275 Liver .d-u 979 to 1255 1 to 277       277/277
(100 %)
0 diff
(100 %id)
BQ002001 lung, Metastatic Chondrosarcoma .d-u 986 to 1806 837 to 19   AAA   819/819
(100 %)
6 diff
(99.3 %id)
TI_149288219   .d-u 988 to 1806 888 to 80   AAA   809/963
(84 %)
18 diff
(98.2 %id)
CA444756 lung, Metastatic Chondrosarcoma .d-u 992 to 1806 831 to 19   AAA   813/813
(100 %)
5 diff
(99.4 %id)
DR158090 human embryonic stem cells differentiated toan early endodermal cell type .d-u 1012 to 1801 1 to 790       790/790
(100 %)
0 diff
(100 %id)
BG251737 adenocarcinoma, cell line, Liver .d-u 1032 to 1681 1 to 650       650/650
(100 %)
0 diff
(100 %id)
TI_154125030   .d-u 1041 to 1806 828 to 79   AAA   750/932
(80 %)
19 diff
(98.0 %id)
CA306361 Alveolar Macrophage, lung .d-u 1052 to 1806 772 to 19   AAA   754/754
(100 %)
1 diff
(99.9 %id)
BU684795 lung, Primary Lung Cystic Fibrosis EpithelialCells .d-u 1064 to 1806 761 to 19   AAA   743/743
(100 %)
0 diff
(100 %id)
TI_154127452   .d-u 1068 to 1799 814 to 85   AAA   730/944
(77 %)
29 diff
(97.0 %id)
BM809970 astrocytoma grade IV, cell line, brain .d-u 1070 to 1807 804 to 64     Submitted on the opposite strand 741/1233
(60 %)
0 diff
(100 %id)
TI_149285587   .d-u 1082 to 1792 792 to 84   AAA   709/709
(100 %)
4 diff
(99.5 %id)
CD365958 Alveolar Macrophage, lung .d-u 1084 to 1806 740 to 19   AAA   722/722
(100 %)
1 diff
(99.9 %id)
TI_154018954   .d-u 1096 to 1806 803 to 93   AAA   711/711
(100 %)
4 diff
(99.5 %id)
BM997073 Chondrosarcoma, Left Pubic Bone .d-u 1102 to 1806 722 to 19   AAA   704/704
(100 %)
1 diff
(99.9 %id)
AA127698 uterus .d-u 1116 to 1815 11 to 711   tiling clone, fully sequenced,   701/711
(98 %)
3 diff
(99.6 %id)
CA437841 lung, Metastatic Chondrosarcoma .d-u 1125 to 1806 700 to 19   AAA   682/682
(100 %)
3 diff
(99.6 %id)
BM988580 lung, Metastatic Chondrosarcoma .d-u 1128 to 1806 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
CA308309 Alveolar Macrophage, lung .d-u 1128 to 1806 695 to 17   AAA   679/679
(100 %)
0 diff
(100 %id)
BQ019832 Chondrosarcoma, Left Pubic Bone .d-u 1129 to 1806 696 to 19   AAA   678/678
(100 %)
0 diff
(100 %id)
BQ001116 lung, Metastatic Chondrosarcoma .d-u 1136 to 1806 689 to 19   AAA   671/671
(100 %)
0 diff
(100 %id)
CA312478 Human Lung Epithelial cells, lung .d-u 1136 to 1806 689 to 19   AAA   671/671
(100 %)
0 diff
(100 %id)
CA421341 Bone, Enchondroma cell line .d-u 1136 to 1806 689 to 19   AAA   671/671
(100 %)
2 diff
(99.8 %id)
BQ019608 Chondrosarcoma, Left Pubic Bone .d-u 1142 to 1806 683 to 19   AAA   665/665
(100 %)
0 diff
(100 %id)
CB305968 lung, Primary Lung Cystic Fibrosis EpithelialCells .d-u 1148 to 1789 660 to 19   AAA   642/642
(100 %)
1 diff
(99.9 %id)
BQ010139 Chondrosarcoma, Left Pubic Bone .d-u 1150 to 1806 675 to 19   AAA   657/657
(100 %)
0 diff
(100 %id)
BQ017664 Chondrosarcoma, Left Pubic Bone .d-u 1160 to 1806 665 to 19   AAA   647/647
(100 %)
0 diff
(100 %id)
BQ326706 colon_normal .d-u 1163 to 1489 346 to 20       327/346
(94 %)
0 diff
(100 %id)
BU617311 Bone, Subchondral Bone .d-u 1185 to 1799 633 to 19   AAA   615/615
(100 %)
0 diff
(100 %id)
AW956415   .d-u 1189 to 1805 617 to 1     Submitted on the opposite strand 617/620
(99 %)
23 diff
(96.3 %id)
TI_159677769   .d-u 1194 to 1806 49 to 662   AAA   614/662
(92 %)
6 diff
(99.1 %id)
BQ028938 Bone, Subchondral Bone .d-u 1219 to 1806 606 to 19   AAA   588/588
(100 %)
0 diff
(100 %id)
CN367561 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d-u 1233 to 1507 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AA187542   .d-u 1262 to 1807 548 to 4     Submitted on the opposite strand 545/548
(99 %)
0 diff
(100 %id)
AW614864 2 pooled high-grade transitional celltumors, genitourinary tract .d-u 1263 to 1806 562 to 19   fully sequenced, AAA   544/544
(100 %)
9 diff
(98.4 %id)
BM726648 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d-u 1274 to 1765 1 to 492       492/492
(100 %)
1 diff
(99.8 %id)
CF130317 Chondrosarcoma Lung Metastasis cell lines, lung .d-u 1275 to 1806 1 to 532   AAA   532/532
(100 %)
0 diff
(100 %id)
TI_154192274   .d-u 1275 to 1806 52 to 583   AAA   532/532
(100 %)
0 diff
(100 %id)
BF095978 uterus_tumor .d-u 1276 to 1647 373 to 2       372/373
(99 %)
0 diff
(100 %id)
BQ378442 uterus_tumor .d-u 1276 to 1614 339 to 2       338/339
(99 %)
0 diff
(100 %id)
AW939718 denis_drash .d-u 1280 to 1676 397 to 1     Submitted on the opposite strand 397/397
(100 %)
1 diff
(99.8 %id)
BQ353845 head_neck .d-u 1286 to 1387 105 to 4       102/109
(93 %)
0 diff
(100 %id)
W69482 heart .d-u 1295 to 1483 1 to 191   fully sequenced,   191/191
(100 %)
0 diff
(100 %id)
BG775276 carcinoma, cell line, Prostate .d-u 1302 to 1806 1 to 505   fully sequenced, AAA   505/505
(100 %)
1 diff
(99.9 %id)
AA121534 uterus .d-u 1303 to 1814 512 to 1   fully sequenced,   512/512
(100 %)
2 diff
(99.7 %id)
BQ378414 uterus_tumor .d-u 1323 to 1627 309 to 3       307/310
(99 %)
0 diff
(100 %id)
CF132043 Chondrosarcoma Lung Metastasis cell lines, lung .d-u 1349 to 1806 1 to 458   AAA   458/458
(100 %)
0 diff
(100 %id)
TI_59395132   .d-u 1353 to 1742 410 to 14   fully sequenced,   397/410
(96 %)
7 diff
(98.3 %id)
BE149039 head_neck .d-u 1359 to 1790 436 to 6     Submitted on the opposite strand 431/458
(94 %)
0 diff
(100 %id)
BE149046 head_neck .d-u 1359 to 1790 434 to 5     Submitted on the opposite strand 430/456
(94 %)
0 diff
(100 %id)
BE149071 head_neck .d-u 1359 to 1790 436 to 6     Submitted on the opposite strand 431/458
(94 %)
0 diff
(100 %id)
BE149078 head_neck .d-u 1359 to 1790 434 to 5     Submitted on the opposite strand 430/456
(94 %)
0 diff
(100 %id)
BE152845 head_neck .d-u 1359 to 1773 470 to 42     Submitted on the opposite strand 429/497
(86 %)
0 diff
(100 %id)
DB509886 testis .d-u 1366 to 1806 1 to 444     Submitted on the opposite strand 444/444
(100 %)
7 diff
(98.5 %id)
AI283271 adenocarcinoma, colon .d-u 1381 to 1806 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI580768 uterus .d-u 1386 to 1806 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AA082096   .d-u 1390 to 1733 1 to 344       344/344
(100 %)
0 diff
(100 %id)
AI354786 lung .d-u 1397 to 1806 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI692210 colon .d-u 1410 to 1807 398 to 1       398/398
(100 %)
0 diff
(100 %id)
BQ376976 uterus .d-u 1421 to 1643 241 to 15       227/241
(94 %)
0 diff
(100 %id)
AA991277 breast .d-u 1422 to 1799 378 to 1       378/378
(100 %)
0 diff
(100 %id)
FN134311 breast carcinoma .d-u 1446 to 1548 104 to 1     Submitted on the opposite strand 104/104
(100 %)
3 diff
(97.2 %id)
AW135528   .d-u 1449 to 1801 370 to 18   AAA   353/353
(100 %)
0 diff
(100 %id)
CB145670 Liver .d-u 1450 to 1807 358 to 1     Submitted on the opposite strand 358/358
(100 %)
1 diff
(99.8 %id)
W69483 heart .d-u 1453 to 1789 337 to 1   fully sequenced,   337/337
(100 %)
0 diff
(100 %id)
CA417142 Chondrosarcoma Cell line .d-u 1457 to 1799 361 to 19   AAA   343/343
(100 %)
0 diff
(100 %id)
BM719252 eye, fetal eye .d-u 1473 to 1763 1 to 290       290/290
(100 %)
2 diff
(99.4 %id)
AA778397 heart .d-u 1498 to 1805 308 to 1       308/308
(100 %)
0 diff
(100 %id)
AA373486 lung .d-u 1527 to 1792 266 to 1     Submitted on the opposite strand 266/266
(100 %)
0 diff
(100 %id)
BG775894 carcinoma, cell line, Prostate .d-u 1539 to 1757 219 to 1   fully sequenced,   219/219
(100 %)
0 diff
(100 %id)
DR978166 brain .d-u 1661 to 1807 1 to 146     Submitted on the opposite strand 146/155
(94 %)
5 diff
(96.8 %id)
CN367565 embryonic stem cells, cell lines H1, H7, andH9 .e 1 to 481 7 to 487   tiling clone,   487/487
(100 %)
1 diff
(99.8 %id)
BE888864 leiomyosarcoma, uterus .e 21 to 772 1 to 738   tiling clone,   738/855
(86 %)
24 diff
(97.2 %id)
DA376475 thalamus .f 1 to 556 2 to 558 V37X D39R S40L A41G L42A ... tiling clone, capped   557/557
(100 %)
4 diff
(99.3 %id)
DA747579   .f 1 to 561 2 to 563 V37X D39R S40L A41G L42A ... tiling clone, capped   562/562
(100 %)
3 diff
(99.5 %id)
BM467441 duodenal adenocarcinoma, cell line, small intestine .f 18 to 806 1 to 792 Q105R tiling clone,   792/1115
(71 %)
12 diff
(99.0 %id)
AK311364   .g 1 to 1493 1 to 1493 Y110H tiling clone,   1493/1493
(100 %)
4 diff
(99.8 %id)
DA377627 thalamus .g 2 to 537 2 to 537 Y110H capped   536/536
(100 %)
2 diff
(99.7 %id)
DA705818   .g 2 to 466 2 to 466   capped   465/465
(100 %)
2 diff
(99.6 %id)
CN289476 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 537 to 792 1 to 256       256/256
(100 %)
2 diff
(99.3 %id)
DA560333 heart .g 584 to 1142 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA890177 rectum .g 586 to 1142 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CB269345 adipose .g 603 to 952 1 to 350       350/350
(100 %)
0 diff
(100 %id)
BP376541 uterus .g 611 to 1171 1 to 560       560/560
(100 %)
7 diff
(98.8 %id)
BP364262 lung .g 627 to 1212 1 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
AA416878   .g 629 to 973 152 to 496     Submitted on the opposite strand 345/496
(69 %)
6 diff
(98.8 %id)
AA470050   .g 664 to 1069 404 to 1     Submitted on the opposite strand 404/404
(100 %)
5 diff
(98.8 %id)
AJ710272 heart .h 1 to 430 1 to 430 exact tiling clone,   430/430
(100 %)
0 diff
(100 %id)
ES315162 occipital scalp hair, skin .h 6 to 180 1 to 173       173/173
(100 %)
7 diff
(96.0 %id)
ES307996 beard hair, skin .h 12 to 204 1 to 192       192/193
(99 %)
4 diff
(98.0 %id)
ES312462 frontal balding hair, skin .h 23 to 180 1 to 158       158/159
(99 %)
5 diff
(96.9 %id)
CV026189 mixed .h 41 to 117 1 to 77       77/77
(100 %)
2 diff
(97.5 %id)
DA693982   .i 1 to 575 2 to 579 G29W I30H D31L P32T A33R ... tiling clone, capped   578/578
(100 %)
4 diff
(99.4 %id)
CN367558 embryonic stem cells, DMSO-treated H9 cellline .j 1 to 399 1 to 400 exact tiling clone,   400/400
(100 %)
1 diff
(99.8 %id)
DA589557 lung .k 1 to 476 9 to 485 exact tiling clone, capped   484/484
(100 %)
3 diff
(99.4 %id)
CV804626 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .l 1 to 791 16 to 808 exact     799/808
(98 %)
23 diff
(97.2 %id)
CD101733 Human Placenta, placenta .l 1 to 720 27 to 753 exact tiling clone,   730/783
(93 %)
18 diff
(97.8 %id)
BU942233 mixed (pool of 40 RNAs) .l 6 to 532 1 to 539 E100G     539/810
(66 %)
17 diff
(98.0 %id)
CO397028 Chondrosarcoma Lung Metastasis cell lines, lung .l 7 to 693 1 to 683 exact     683/850
(80 %)
10 diff
(98.9 %id)
CD689222 normal nasopharynx .l 9 to 539 33 to 564 N14D     532/564
(94 %)
6 diff
(99.0 %id)
BP871973 embryonal kidney .l 9 to 589 1 to 581 Y50F A63G     581/581
(100 %)
4 diff
(99.4 %id)
CD701728 normal nasopharynx .l 12 to 624 17 to 629 exact     613/629
(97 %)
6 diff
(99.1 %id)
BE336782 Kidney, renal cell adenocarcinoma .l 13 to 181 1 to 169       169/169
(100 %)
0 diff
(100 %id)
CN425729 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 14 to 510 1 to 497 exact     497/497
(100 %)
2 diff
(99.6 %id)
BQ920142 epidermoid carcinoma, cell line, lung .l 16 to 780 1 to 765 exact     765/926
(82 %)
1 diff
(99.9 %id)
BM908138 brain, medulla .l 17 to 1011 7 to 1005 exact     999/1061
(94 %)
33 diff
(96.9 %id)
BQ478385 insulinoma, Pancreas .l 18 to 460 10 to 452 N52I E53V fully sequenced,   443/452
(98 %)
9 diff
(98.1 %id)
BQ548846 insulinoma, Pancreas .l 18 to 515 10 to 507 exact fully sequenced,   498/507
(98 %)
6 diff
(98.9 %id)
CF242899 Brain glioblastoma .l 18 to 870 1 to 858 exact     858/858
(100 %)
8 diff
(99.1 %id)
CF128510 Chondrosarcoma Lung Metastasis cell lines, lung .l 18 to 701 12 to 693 V5C H6T I7P Q8G A9G ...     682/693
(98 %)
12 diff
(98.3 %id)
TI_154194414   .l 18 to 853 49 to 879 V5C H6T I7P Q8G A9G ...     831/1019
(81 %)
47 diff
(95.4 %id)
EL954664 eyeball .l 24 to 605 19 to 600 exact     582/600
(97 %)
8 diff
(98.7 %id)
BC039717 Brain, adult medulla .l 24 to 1008 1 to 985 exact tiling clone, AAA   985/985
(100 %)
0 diff
(100 %id)
BU527222 epidermoid carcinoma, cell line, lung .l 28 to 874 1 to 855 exact     855/860
(99 %)
9 diff
(99.0 %id)
BF692266 melanotic melanoma, high MDR, skin .l 35 to 714 1 to 677 W21G E22K V23*     677/865
(78 %)
37 diff
(95.8 %id)
CD300776 White Matter .l 37 to 878 1 to 851 exact     851/851
(100 %)
20 diff
(97.7 %id)
CN425734 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 42 to 690 1 to 650 exact     650/650
(100 %)
1 diff
(99.9 %id)
CA950058 Pancreas, Purified pancreatic islet .l 42 to 498 1 to 458 E3D G71M T72H M73H D74G ... fully sequenced,   458/458
(100 %)
4 diff
(99.2 %id)
T83838 liver and spleen .l 73 to 428 10 to 365       356/365
(97 %)
15 diff
(95.9 %id)
CN425718 embryonic stem cells, cell lines H1, H7, andH9 .l 80 to 726 1 to 647       647/647
(100 %)
0 diff
(100 %id)
CD518319 White Matter .l 111 to 584 1 to 492   AAA   492/713
(69 %)
24 diff
(96.7 %id)
TI_154057187   .l 220 to 1008 873 to 89   AAA   785/987
(79 %)
8 diff
(99.2 %id)
AA516323 liposarcoma .l 242 to 390 1 to 149       149/149
(100 %)
6 diff
(96.0 %id)
BQ009447 Chondrosarcoma, Left Pubic Bone .l 330 to 1007 694 to 17   AAA   678/683
(99 %)
0 diff
(100 %id)
CA418969 Chondrosarcoma Grade II, Left Pelvis .l 331 to 1008 696 to 19   AAA   678/678
(100 %)
2 diff
(99.8 %id)
AW385915 leiomios .l 346 to 621 1 to 275       275/275
(100 %)
16 diff
(94.2 %id)
CD369755 Alveolar Macrophage, lung .l 369 to 1008 658 to 19   AAA   640/640
(100 %)
4 diff
(99.4 %id)
BQ478147 insulinoma, Pancreas .l 430 to 1008 594 to 16   fully sequenced, AAA   579/579
(100 %)
1 diff
(99.9 %id)
BE844040 testis_normal .l 463 to 795 1 to 332       332/337
(98 %)
8 diff
(97.7 %id)
CA943858 Pancreas, Purified pancreatic islet .l 468 to 1007 540 to 1   fully sequenced,   540/540
(100 %)
0 diff
(100 %id)
BF846085 lung_normal .l 471 to 867 29 to 424       396/441
(89 %)
2 diff
(99.6 %id)
BQ548688 insulinoma, Pancreas .l 485 to 1008 539 to 16   fully sequenced, AAA   524/524
(100 %)
1 diff
(99.9 %id)
FN081568 breast carcinoma .l 487 to 555 1 to 68       68/68
(100 %)
1 diff
(98.6 %id)
BF854753 prostate_normal .l 522 to 747 1 to 226       226/239
(94 %)
3 diff
(98.8 %id)
AA147413   .l 573 to 984 1 to 414   fully sequenced,   414/414
(100 %)
11 diff
(97.4 %id)
Z24909 leg muscle, skeletal muscle .l 590 to 925 1 to 336       336/336
(100 %)
8 diff
(97.7 %id)
BE840972 stomach_normal .l 636 to 1092 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
BF060924 follicular carcinoma, thyroid .l 642 to 1011 374 to 5       370/393
(94 %)
0 diff
(100 %id)
AA147320   .l 659 to 1008 355 to 1   fully sequenced,   355/355
(100 %)
7 diff
(98.1 %id)
AW189350 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 677 to 1009 333 to 1       333/333
(100 %)
1 diff
(99.7 %id)
BG113281 Bone, osteosarcoma, cell line .l 969 to 1444 1 to 482   tiling clone,   482/1002
(48 %)
22 diff
(97.9 %id)
CD106592 brain, Pituitary .l 1205 to 1519 1 to 315   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 315/315
(100 %)
1 diff
(99.7 %id)
BU540737 epithelioid carcinoma cell line, Pancreas .l 1350 to 2241 1 to 901   tiling clone,   901/901
(100 %)
14 diff
(98.5 %id)
AW875140 pnet .l 1471 to 1965 9 to 502   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 494/502
(98 %)
6 diff
(98.9 %id)
BE315422 adenocarcinoma cell line, ovary .l 1562 to 2199 1 to 635       635/685
(92 %)
29 diff
(95.8 %id)
BE743252 adenocarcinoma cell line, ovary .l 1562 to 2388 1 to 830       830/919
(90 %)
29 diff
(96.9 %id)
W07861 lung .l 1734 to 2114 1 to 386       386/404
(95 %)
9 diff
(97.8 %id)
CA394661 eye, RPE/choroid .l 1769 to 2291 33 to 558       526/558
(94 %)
6 diff
(99.0 %id)
CN277634 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 1821 to 2510 1 to 690   tiling clone,   690/690
(100 %)
6 diff
(99.2 %id)
TI_157608570   .l 2044 to 2662 721 to 103   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 619/869
(71 %)
7 diff
(99.2 %id)
BF511636   .l 2071 to 2662 604 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 587/589
(99 %)
16 diff
(97.3 %id)
TI_158435753   .l 2090 to 2658 670 to 100   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 571/575
(99 %)
0 diff
(100 %id)
BF510855   .l 2098 to 2662 582 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 565/565
(100 %)
1 diff
(99.9 %id)
N21031 melanocyte .l 2109 to 2662 554 to 1   tiling clone,   554/554
(100 %)
9 diff
(98.4 %id)
BF444962 carcinoid, lung .l 2116 to 2589 8 to 481     Submitted on the opposite strand 474/481
(98 %)
6 diff
(98.8 %id)
BG149219 carcinoid, lung .l 2116 to 2607 8 to 497     Submitted on the opposite strand 490/497
(98 %)
10 diff
(98.0 %id)
AI690069 carcinoid, lung .l 2128 to 2608 1 to 481     Submitted on the opposite strand 481/481
(100 %)
1 diff
(99.8 %id)
BE645654 Prostate .l 2165 to 2663 504 to 5       500/504
(99 %)
0 diff
(100 %id)
AI476774 pooled .l 2168 to 2663 500 to 5   tiling clone,   496/500
(99 %)
0 diff
(100 %id)
AI095242 senescent fibroblast .l 2171 to 2662 500 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 490/493
(99 %)
3 diff
(99.4 %id)
AI735444 aorta .l 2203 to 2656 465 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 454/454
(100 %)
10 diff
(97.8 %id)
AI129276 uterus .l 2230 to 2663 435 to 2       434/435
(99 %)
0 diff
(100 %id)
AI591041 ovary, tumor, 5 pooled (see description) .l 2230 to 2663 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
AI219905 pooled .l 2237 to 2663 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
AI148241 senescent fibroblast .l 2240 to 2662 434 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 423/423
(100 %)
2 diff
(99.6 %id)
N81051 lung .l 2246 to 2662 420 to 1       420/420
(100 %)
4 diff
(99.1 %id)
AW236759 Kidney .l 2250 to 2662 413 to 1       413/413
(100 %)
1 diff
(99.8 %id)
AI689543 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 2253 to 2663 417 to 7       411/418
(98 %)
0 diff
(100 %id)
AA815339   .l 2270 to 2490 221 to 1       221/221
(100 %)
0 diff
(100 %id)
BX113862 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 2270 to 2662 407 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
BE150969 head_neck .l 2335 to 2501 171 to 6     Submitted on the opposite strand 166/180
(92 %)
0 diff
(100 %id)
AI867483 Prostate .l 2341 to 2663 330 to 8       323/330
(97 %)
0 diff
(100 %id)
DA038061   .m 1 to 564 2 to 566 V37X D39R S40L A41G L42A ... capped   565/567
(99 %)
2 diff
(99.7 %id)
DA701971   .m 1 to 512 2 to 512 P61S A64S F81L Q83S L84F ... tiling clone, capped   511/511
(100 %)
3 diff
(99.5 %id)
DA718262   .m 1 to 569 2 to 571 V37C D39R S40L A41G L42A ... capped   570/570
(100 %)
2 diff
(99.7 %id)
DA981866 synovial membrane tissue from rheumatioidarthritis .m 1 to 551 2 to 552 exact capped   551/551
(100 %)
3 diff
(99.5 %id)
DA044439 bladder .m 2 to 560 2 to 561 V37X D39R S40L A41G L42A ... capped   560/560
(100 %)
1 diff
(99.9 %id)
DA765796 tongue .m 4 to 568 2 to 566 exact capped   565/565
(100 %)
1 diff
(99.9 %id)
DA886481   .m 4 to 568 2 to 566 exact capped   565/565
(100 %)
1 diff
(99.9 %id)
DA653633   .m 5 to 544 2 to 542 L42P Q43A L44A E45G R46E ... capped   541/541
(100 %)
2 diff
(99.7 %id)
DA577357   .m 8 to 558 2 to 554 D26* capped   553/553
(100 %)
2 diff
(99.7 %id)
DA199104 brain .m 11 to 569 2 to 561 V37X D39R S40L A41G L42A ... capped   560/560
(100 %)
3 diff
(99.5 %id)
CV815791 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .m 16 to 787 1 to 772 exact tiling clone,   772/772
(100 %)
2 diff
(99.8 %id)
CB138340 Liver .m 35 to 629 1 to 595 exact     595/595
(100 %)
1 diff
(99.9 %id)
DA556040   .m 36 to 583 2 to 551 V49X Y50L Y51L N52Q E53* capped   550/550
(100 %)
2 diff
(99.7 %id)
BE887505 leiomyosarcoma, uterus .m 43 to 725 1 to 683 exact tiling clone,   683/683
(100 %)
4 diff
(99.5 %id)
AW300206 Kidney .n 1 to 551 551 to 1 exact tiling clone,   551/551
(100 %)
0 diff
(100 %id)
ES307967 beard hair, skin .n 26 to 166 1 to 138       138/143
(96 %)
7 diff
(95.2 %id)
AI658812 Prostate .n 193 to 551 363 to 4       360/363
(99 %)
3 diff
(99.2 %id)
AI973083 Prostate .n 193 to 551 362 to 4       359/362
(99 %)
0 diff
(100 %id)
BG197151   .n 271 to 551 1 to 281   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 281/281
(100 %)
5 diff
(98.3 %id)
AA505786 breast .n 338 to 550 213 to 1       213/213
(100 %)
0 diff
(100 %id)
AI383189 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 359 to 554 203 to 8       196/203
(96 %)
0 diff
(100 %id)
BF991452 placenta_normal .n 461 to 631 177 to 2   tiling clone,   176/193
(91 %)
0 diff
(100 %id)
BP265267 thyroid .o 1 to 570 9 to 578 exact tiling clone,   578/578
(100 %)
4 diff
(99.4 %id)
BJ997975 Wilms tumor .p-u 1 to 600 1 to 600   tiling clone,   600/600
(100 %)
0 diff
(100 %id)
AA807803 alveolar rhabdomyosarcoma .p-u 435 to 624 1 to 190       190/196
(96 %)
8 diff
(96.0 %id)
DB534914 hippocampus .p-u 436 to 878 445 to 2       444/445
(99 %)
0 diff
(100 %id)
DB537130 hippocampus .p-u 436 to 861 427 to 1       427/427
(100 %)
2 diff
(99.6 %id)
DB513547 testis .p-u 438 to 856 415 to 1       415/415
(100 %)
21 diff
(95.0 %id)
BQ267635 insulinoma, Pancreas .p-u 439 to 690 28 to 279       252/428
(58 %)
1 diff
(99.8 %id)
DB532964 hippocampus .p-u 450 to 891 440 to 3       438/440
(99 %)
0 diff
(100 %id)
BP385272 pancreatic islet .p-u 470 to 837 369 to 1       369/369
(100 %)
1 diff
(99.8 %id)
BP388686 pancreatic islet .p-u 598 to 1091 494 to 1 V19X tiling clone,   494/496
(99 %)
1 diff
(99.8 %id)
AJ707831 heart .p-u 603 to 1138 17 to 552 exact tiling clone,   536/552
(97 %)
6 diff
(99.0 %id)
DB519690.
matches multiple genes
testis .p-u 608 to 1060 453 to 1 exact tiling clone, also hits gene AFG3L2 453/453
(100 %)
0 diff
(100 %id)
AK298196   Gene TUBB6, variant not shown         Suspected internal deletion, this clone was ignored    
AK304616 uterus Gene TUBB6, variant not shown         Suspected internal deletion, this clone was ignored    
DC360766   Gene TUBB6, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154128879   Gene TUBB6, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DC421300 uterus Gene TUBB6, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C